现代数据在世卫组织淋巴肉瘤分类中的整合。其对预后预测和根据预后调整治疗的价值。
Integration of modern data in WHO categorization of lymphosarcomas. Its value for prognosis prediction and therapeutic adaptation to prognosis.
作者信息
Mathé G
出版信息
Recent Results Cancer Res. 1978;64:5-18. doi: 10.1007/978-3-642-81246-0_2.
PMID:366705
Abstract
The categorization of lymphosarcomas with immune markers has enriched the prognosis value of the WHO classification. The prolymphocytic (centrofollicular) B-type and the null lymphoblastic subtype have a good prognosis, while the (T- or B-) immunoblastic type and the T-lymphoblastic subtype have a poor prognosis.
摘要
通过免疫标记对淋巴肉瘤进行分类丰富了世界卫生组织分类的预后价值。前淋巴细胞（中心滤泡）B型和无标记淋巴母细胞亚型预后良好，而（T或B）免疫母细胞型和T淋巴母细胞亚型预后较差。
Zotero 插件